Patient-first virtual care for pharma & life sciences brands
From clinical trials to post-LOE, Wheel helps you enhance commercialization through compliant, patient-first virtual care that improves access, builds trust, and drives brand performance on a platform built for scale.
Accelerate launches with lower lift
Streamline commercialization with prebuilt infrastructure and ready-to-deploy clinical programs. Launch faster, reduce internal complexity, and maintain security, compliance, and scalability from day one.
Deliver trusted, evidence-based care
Provide clinically sound, unbiased care through an independent network of providers. Improve patient access and time-to-treatment while supporting measurable outcomes across therapeutic areas.
Drive adherence and long-term brand value
Support patients across entire care journeys and condition areas. Extend brand relevance post-LOE by building relationships that foster engagement, loyalty, and lasting impact.
Wheel Horizon™: Built for scalable, patient-first care
Deliver high-quality telemedicine services at scale on a platform patients love.
- Library of 70+ Proven Care Programs
- Seamless Patient Experience
- High-Quality 50-state independent clinician network
- Open Ecosystem & Native Partner Integrations
- Extensive database and intelligence reporting
- SOC II and HIPAA-compliant, with robust monitoring tools
Discover how leading pharma companies are enhancing brand engagement in the era of telehealth
Pharma brand engagement
Telehealth is redefining how pharma brands engage with patients, offering new opportunities to strengthen connections and improve interactions. Explore key strategies, trends, and frameworks driving the future of digital engagement in the pharmaceutical industry.
Bringing pharma closer to patients
Huma and Wheel are revolutionizing pharma-patient connections through digital health solutions. By combining remote patient monitoring and telehealth, they enhance access, engagement, and care delivery. Discover how their collaboration is shaping the future of patient-centric pharmaceutical services.
